IE38780L - Metabolite a-27106 - Google Patents

Metabolite a-27106

Info

Publication number
IE38780L
IE38780L IE740129A IE12974A IE38780L IE 38780 L IE38780 L IE 38780L IE 740129 A IE740129 A IE 740129A IE 12974 A IE12974 A IE 12974A IE 38780 L IE38780 L IE 38780L
Authority
IE
Ireland
Prior art keywords
metabolite
feed
monensin
carbon
molecular weight
Prior art date
Application number
IE740129A
Other versions
IE38780B1 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IE38780L publication Critical patent/IE38780L/en
Publication of IE38780B1 publication Critical patent/IE38780B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Fodder In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

1457796 Metabolite A-27106 ELI LILLY & CO 30 Jan 1974 [1 Feb 1973] 04414/74 Headings C2A and C2C The invention relates to Metabolite A-27106 and the acid, ammonium, lithium, potassium, rubidium or cesium forms thereof. The metabolite is a white crystalline solid with (a) a molecular weight of 854, as determined by mass spectrometry; (b) an elemental composition of 58À78% carbon, 8À51% hydrogen, 27À85% oxygen and 3À63% sodium; (c) an empirical formula of C 42 H 71 O 16 Na; (d) an infra-red absorption spectrum in chloroform as shown in the accompanying drawing; (e) a mass spectrum having a molecular-ion peak at m./e. 854À44630 and characteristic peaks at m./e. 836À44129, 779À44690, 761À44740; and (f) an Rf value of 0À49 on silica gel thin layer chromatography in benzene-methanol (7 : 3); and the acid form is a white solid having a molecular weight of 832 and a titratable group with a pKa value of 7À2. The following structure is proposed for Metabolite A-27106. Metabolite A-27106 is prepared by cultivating Streptomyces candidus NRRL 5449 in a culture medium containing assimilable sources of carbon, nitrogen and inorganic salts under submerged aerobic conditions in the presence of glucose and monensin until monensin is converted into metabolite A-27106. The metabolite may be mixed with a physiologically-acceptable carrier, e.g. poultry feed, and administered to poultry for preventing or treating coccidiosis therein. The metabolite may also be mixed with ruminant feed for increasing the efficiency of feed utilization of ruminant animals. [GB1457796A]
IE129/74A 1973-02-01 1974-01-22 Metabolite a-27106 and process for its preparation and us IE38780B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32858673A 1973-02-01 1973-02-01

Publications (2)

Publication Number Publication Date
IE38780L true IE38780L (en) 1974-08-01
IE38780B1 IE38780B1 (en) 1978-05-24

Family

ID=23281582

Family Applications (1)

Application Number Title Priority Date Filing Date
IE129/74A IE38780B1 (en) 1973-02-01 1974-01-22 Metabolite a-27106 and process for its preparation and us

Country Status (27)

Country Link
JP (2) JPS5730477B2 (en)
AR (1) AR206509A1 (en)
AT (1) AT328083B (en)
BE (1) BE810416A (en)
BG (1) BG26953A3 (en)
CA (1) CA1016483A (en)
CH (1) CH589140A5 (en)
CS (1) CS193481B2 (en)
DD (1) DD112441A5 (en)
DE (1) DE2404958C2 (en)
DK (1) DK143036C (en)
EG (1) EG11287A (en)
ES (1) ES422834A1 (en)
FI (1) FI52993C (en)
FR (1) FR2215943B1 (en)
GB (1) GB1457796A (en)
HU (1) HU167276B (en)
IE (1) IE38780B1 (en)
IL (1) IL44065A (en)
IN (1) IN139462B (en)
NL (1) NL181367C (en)
NO (1) NO139788C (en)
PH (1) PH12449A (en)
SE (1) SE401930B (en)
SU (1) SU539538A3 (en)
YU (1) YU36990B (en)
ZA (1) ZA74464B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6384471U (en) * 1986-11-21 1988-06-02
JPH0483920U (en) * 1990-11-30 1992-07-21
JPH0512236U (en) * 1991-07-26 1993-02-19 東京ラヂエーター製造株式会社 Fuel tank backflow prevention structure

Also Published As

Publication number Publication date
DK143036B (en) 1981-03-16
BG26953A3 (en) 1979-07-12
JPS5730477B2 (en) 1982-06-29
FI52993C (en) 1978-01-10
JPS5798211A (en) 1982-06-18
DE2404958A1 (en) 1974-08-22
ATA76874A (en) 1975-05-15
NL181367C (en) 1987-08-03
EG11287A (en) 1977-01-31
AR206509A1 (en) 1976-07-30
NO139788C (en) 1979-05-09
IL44065A0 (en) 1974-05-16
FR2215943B1 (en) 1978-07-28
NL7401311A (en) 1974-08-05
FI52993B (en) 1977-09-30
YU36990B (en) 1984-08-31
CS193481B2 (en) 1979-10-31
YU19074A (en) 1982-02-25
JPS49102888A (en) 1974-09-28
SU539538A3 (en) 1976-12-15
CA1016483A (en) 1977-08-30
SE401930B (en) 1978-06-05
HU167276B (en) 1975-09-27
NL181367B (en) 1987-03-02
NO139788B (en) 1979-01-29
PH12449A (en) 1979-03-08
DK143036C (en) 1981-10-26
GB1457796A (en) 1976-12-08
IL44065A (en) 1977-03-31
JPS6026374B2 (en) 1985-06-24
IE38780B1 (en) 1978-05-24
DD112441A5 (en) 1975-04-12
CH589140A5 (en) 1977-06-30
BE810416A (en) 1974-07-31
NO740292L (en) 1974-08-02
DE2404958C2 (en) 1985-04-18
AT328083B (en) 1976-03-10
ZA74464B (en) 1975-08-27
IN139462B (en) 1976-06-19
FR2215943A1 (en) 1974-08-30
ES422834A1 (en) 1976-09-16
AU6473774A (en) 1975-07-24

Similar Documents

Publication Publication Date Title
UA8335A1 (en) The method for the fermentation of microorganisms of alkaligenes entrophus for the obtainment of the cells, containing poly-beta-oxybutyric acid
JPS53138446A (en) Resin composition
ES8305044A1 (en) Process for preparing optically pure D- or L-lactic acid.
IE38780B1 (en) Metabolite a-27106 and process for its preparation and us
GB1314657A (en) Antibiotics
KR880701727A (en) Preparation of antibiotic 10381b
PT72825B (en) Process for the preparation of an injectable oxytetracycline composition
JPS575692A (en) Production of l-arginine through fermentation process
JPS5635985A (en) Stabilization of glutamic acid dehydrogenase
JPS527916A (en) Process for preparation of oxamido
ES8706326A1 (en) Mitomycin derivatives
GB1388878A (en) Antibiotics process for their production and use in ruminant feed
IE45349L (en) Antibiotic bl580 delta
GB1500847A (en) Antibiotic a process for its preparation and its use as a medicament
GB1330900A (en) Antibiotic thiopeptin compound and the preparation thereof
GB1500846A (en) Antibiotic a process for its preparation and its use as a medicament
JPS5247977A (en) Semi-batch process of fermentation wherein feed rate of substrate or i ts solution is increased exponentially with time
IE41079L (en) Antibiotics a-28086
ATE57953T1 (en) TRIOXA FUEL WITH INCREASED HEAT RETENTION.
JPS5396379A (en) Peocess for producing microbial cells
GB1244717A (en) Fermentative production of l-lysine
JPS5272886A (en) Preparation of cephalosporin compound
KR830002034A (en) Istamycin and its preparation
GB1439668A (en) Antibiotic bm123 and production thereof
JPS5768793A (en) Preparation of l-threonine by fermentation